Critchfield G C, Bennett S T, Swaim W R
Corning Clinical Laboratories, Teterboro, New Jersey, USA.
Am J Clin Pathol. 1996 Dec;106(6):786-94. doi: 10.1093/ajcp/106.6.786.
The International Normalized Ratio (INR) system for reporting the prothrombin time (PT) is essentially a calibration activity intended to standardize PT reporting across various reagent/instrument systems. However, complete standardization of PT reporting through the INR has been difficult to achieve for a variety of reasons, including inaccurate assignment of thromboplastin International Sensitivity Indexes (ISIs) and specific (local) reagent/instrument effects. Until now, the individual laboratory has not been able to easily verify the accuracy of its INR. Using standard lyophilized plasmas with INR values assigned against IRP RBT/90 rabbit thromboplastin, the authors present a method that allows a laboratory to locally verify its range of accuracy for the INR. The method is illustrated on a single coagulometer with two thromboplastin lots of differing sensitivity (Pacific Hemostasis Thromboplastin-DS and Thromboplastin-D from rabbit sources, with respective International Sensitivity Indexes of 1.20 and 1.97). In this illustration of the method, the accuracy of Thromboplastin-DS was superior to that of Thromboplastin-D. Interpretation of the data and cautions regarding the use of standard plasmas for calibration verification are discussed. Using this method, a reportable range of accuracy at a given error tolerance can be established locally for INR measurements within a laboratory. Laboratories of any size can apply this method to study the accuracy of their INR reagent/instrument systems, thus performing calibration verification. When used in conjunction with assessments of assay precision, this method can help laboratories to select better reagent/instrument systems and thereby produce more accurate and more clinically meaningful INR results.
用于报告凝血酶原时间(PT)的国际标准化比值(INR)系统本质上是一种校准活动,旨在使PT报告在各种试剂/仪器系统之间实现标准化。然而,由于多种原因,包括凝血活酶国际敏感指数(ISI)的不准确赋值以及特定(本地)试剂/仪器的影响,通过INR实现PT报告的完全标准化一直难以达成。到目前为止,单个实验室一直无法轻松验证其INR的准确性。作者使用针对国际参考品RBT/90兔凝血活酶赋值了INR值的标准冻干血浆,提出了一种方法,使实验室能够在本地验证其INR的准确范围。该方法在一台单一的凝血仪上进行了演示,使用了两种敏感性不同的凝血活酶批次(太平洋止血凝血活酶-DS和兔源的凝血活酶-D,国际敏感指数分别为1.20和1.97)。在该方法的演示中,凝血活酶-DS的准确性优于凝血活酶-D。文中讨论了数据的解读以及关于使用标准血浆进行校准验证的注意事项。使用这种方法,可以在实验室本地为INR测量建立在给定误差容限下的可报告准确范围。任何规模的实验室都可以应用此方法来研究其INR试剂/仪器系统的准确性,从而进行校准验证。当与检测精密度评估结合使用时,该方法可以帮助实验室选择更好的试剂/仪器系统,从而产生更准确且更具临床意义的INR结果。